Back to Search
Start Over
GenEdit Reports Multiyear Collaboration and License Agreement with Genentech
- Source :
- Plus Company Updates. January 24, 2024
- Publication Year :
- 2024
-
Abstract
- South San Francisco: GenEdit, Inc., a developer of genetic medicines that leverage its NanoGalaxy(r) platform for tissue-selective delivery, announced a multiyear collaboration and license agreement with Genentech, a member of [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.782000721